Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort
PLOS One · 2026
DOI: 10.1371/journal.pone.0356721 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Gary Duclos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Unit, Hospital Nord, Assistance Publique Hôpitaux Universitaires de Marseille, Marseille, France. Hauptthemen laut MEDLINE: Hydrocortisone, Sepsis, Cross Infection. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Purpose
Corticosteroids are suggested for selected patients with septic shock, but their association with outcomes has not been specifically investigated in patients with hospital-acquired bloodstream infections (HA-BSI). We explored the association between hydrocortisone use and day-28 mortality in this population.
Methods
Data from the prospective EUROBACT-2 study were used to assess the association between hydrocortisone use and day-28 mortality in ICU patients with HA-BSI and sepsis. Patients receiving hydrocortisone were compared with patients not receiving hydrocortisone. A 1:1 propensity score matching procedure was performed using nearest-neighbour matching without replacement and a caliper of 0.2 standard deviation of the logit propensity score, followed by multivariable logistic regression with cluster-robust standard errors by matched pair.
Results
Among 2,401 analyzed patients, 608 (25%) received hydrocortisone during the HA-BSI episode. The final propensity score included age, sex, Charlson comorbidity score, ICU admission diagnosis, SOFA score without cardiovascular component, septic shock, country of inclusion, lactate at HA-BSI diagnosis, and ICU-acquired versus non-ICU-acquired HA-BSI. Matching yielded 521 pairs (1,042 patients). In the multivariable model, hydrocortisone use was associated with increased day-28 mortality in the overall matched cohort (OR 1.448; 95% CI 1.096–1.914; p = 0.009). This association was observed in patients with sepsis without shock (OR 1.697; 95% CI 1.051–2.740; p = 0.031) and in the female subgroup (OR 1.718; 95% CI 1.055–2.796; p = 0.030), but not in patients with septic shock or in those receiving norepinephrine-equivalent dose ≥0.25 µg/kg/min.
Conclusion
Hydrocortisone use was not associated with improved day-28 survival in ICU patients with HA-BSI. In the matched analysis, hydrocortisone use was associated with higher day-28 mortality in the overall cohort, whereas no significant association was observed in patients with septic shock or high-dose norepinephrine. These findings are observational and hypothesis-generating and should not be interpreted causally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Unit, Hospital Nord, Assistance Publique Hôpitaux Universitaires de Marseille, Marseille, France.
- Centre d'Etudes et de Recherches sur les services de santé et qualité de vie EA 3279, Aix Marseille Université, Marseille, France.
- Intensive Care Unit, Redcliffe Hospital, Brisbane, Australia.
- Queensland University of Technology, Brisbane, Queensland, Australia.
- Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
- Université de Paris, INSERM, IAME UMR 1137, Paris, France.
ORCID-Profile: Gary Duclos
Zitieren
APA
Duclos, G., Boucekine, M., Tabah, A., Ruckly, S., Buetti, N., Timsit, J. F., Leone, M., EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP, & OUTCOMEREA Network (2026). Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort. PLOS One. https://doi.org/10.1371/journal.pone.0356721
Vancouver
Duclos G, Boucekine M, Tabah A, Ruckly S, Buetti N, Timsit JF, et al. Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort. PLOS One. 2026. doi:10.1371/journal.pone.0356721
BibTeX
@article{Duclos2026,
author = {Duclos, Gary and Boucekine, Mohamed and Tabah, Alexis and Ruckly, Stéphane and Buetti, Niccolò and Timsit, Jean François and Leone, Marc and EUROBACT-2 Study Group, EUROBACT-2 Study Group and ESICM, ESICM and ESCMID ESGCIP, ESCMID ESGCIP and OUTCOMEREA Network, OUTCOMEREA Network},
title = {Association between hydrocortisone use and outcomes in sepsis patients with hospital-acquired bloodstream infections: An ancillary analysis of the EUROBACT-2 cohort},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0356721}
}
EUVIMED